OPKO Health Return on Investment 2012-2026 | OPK
Current and historical return on investment (ROI) values for OPKO Health (OPK) over the last 10 years.
| OPKO Health ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2026-06-30 | $-0.05B | $1.57B | -3.05% |
| 2026-03-31 | $-0.10B | $1.60B | -6.32% |
| 2025-12-31 | $-0.12B | $1.62B | -7.21% |
| 2025-09-30 | $-0.11B | $1.67B | -6.71% |
| 2025-06-30 | $-0.15B | $1.72B | -8.50% |
| 2025-03-31 | $-0.15B | $1.71B | -8.68% |
| 2024-12-31 | $-0.15B | $1.70B | -8.97% |
| 2024-09-30 | $-0.19B | $1.65B | -11.40% |
| 2024-06-30 | $-0.27B | $1.61B | -16.55% |
| 2024-03-31 | $-0.20B | $1.65B | -11.93% |
| 2023-12-31 | $-0.16B | $1.69B | -9.27% |
| 2023-09-30 | $-0.14B | $1.74B | -8.24% |
| 2023-06-30 | $-0.17B | $1.76B | -9.47% |
| 2023-03-31 | $-0.19B | $1.81B | -10.23% |
| 2022-12-31 | $-0.23B | $1.83B | -12.39% |
| 2022-09-30 | $-0.23B | $1.85B | -12.65% |
| 2022-06-30 | $-0.11B | $1.90B | -5.70% |
| 2022-03-31 | $-0.09B | $1.89B | -4.81% |
| 2021-12-31 | $0.02B | $1.92B | 0.99% |
| 2021-09-30 | $0.13B | $1.92B | 6.81% |
| 2021-06-30 | $0.12B | $1.90B | 6.07% |
| 2021-03-31 | $0.14B | $1.87B | 7.29% |
| 2020-12-31 | $0.06B | $1.83B | 3.12% |
| 2020-09-30 | $-0.10B | $1.81B | -5.75% |
| 2020-06-30 | $-0.17B | $1.81B | -9.11% |
| 2020-03-31 | $-0.24B | $1.84B | -13.00% |
| 2019-12-31 | $-0.27B | $1.89B | -14.45% |
| 2019-09-30 | $-0.25B | $1.90B | -13.24% |
| 2019-06-30 | $-0.25B | $1.89B | -12.94% |
| 2019-03-31 | $-0.20B | $1.88B | -10.79% |
| 2018-12-31 | $-0.17B | $1.86B | -9.20% |
| 2018-09-30 | $-0.24B | $1.87B | -12.81% |
| 2018-06-30 | $-0.25B | $1.93B | -13.14% |
| 2018-03-31 | $-0.28B | $2.00B | -13.73% |
| 2017-12-31 | $-0.28B | $2.07B | -13.38% |
| 2017-09-30 | $-0.19B | $2.14B | -9.04% |
| 2017-06-30 | $-0.17B | $2.15B | -7.88% |
| 2017-03-31 | $-0.12B | $2.13B | -5.41% |
| 2016-12-31 | $-0.10B | $2.10B | -4.67% |
| 2016-09-30 | $-0.03B | $2.07B | -1.54% |
| 2016-06-30 | $-0.02B | $2.04B | -0.79% |
| 2016-03-31 | $-0.07B | $1.76B | -3.93% |
| 2015-12-31 | $-0.10B | $1.48B | -6.65% |
| 2015-09-30 | $-0.12B | $1.21B | -10.09% |
| 2015-06-30 | $-0.16B | $0.96B | -16.95% |
| 2015-03-31 | $-0.17B | $0.98B | -17.56% |
| 2014-12-31 | $-0.15B | $1.01B | -14.31% |
| 2014-09-30 | $-0.15B | $1.04B | -14.29% |
| 2014-06-30 | $-0.12B | $1.06B | -11.30% |
| 2014-03-31 | $-0.10B | $0.93B | -11.08% |
| 2013-12-31 | $-0.08B | $0.82B | -9.82% |
| 2013-09-30 | $-0.05B | $0.54B | -9.94% |
| 2013-06-30 | $-0.04B | $0.32B | -13.79% |
| 2013-03-31 | $-0.04B | $0.24B | -14.75% |
| 2012-12-31 | $-0.04B | $0.13B | -27.92% |
| 2012-09-30 | $-0.04B | $0.18B | -19.55% |
| 2012-06-30 | $-0.03B | $0.16B | -19.94% |
| 2012-03-31 | $-0.03B | $0.15B | -19.28% |
| 2011-12-31 | $-0.02B | $0.13B | -17.39% |
| 2011-09-30 | $-0.01B | $0.09B | -13.99% |
| 2011-06-30 | $-0.01B | $0.06B | -16.81% |
| 2011-03-31 | $-0.01B | $0.03B | -35.20% |
| 2010-12-31 | $-0.01B | 0 | 0.00% |
| 2010-09-30 | $-0.02B | $0.01B | -136.17% |
| 2010-06-30 | $-0.02B | $0.03B | -57.14% |
| 2010-03-31 | $-0.02B | $0.05B | -37.99% |
| 2009-12-31 | $-0.02B | $0.05B | -47.57% |
| 2009-09-30 | $-0.03B | $0.04B | -76.32% |
| 2009-06-30 | $-0.03B | $0.02B | -131.91% |
| 2009-03-31 | $-0.04B | $0.01B | -269.09% |
| 2008-12-31 | $-0.04B | $0.02B | -219.72% |
| 2008-09-30 | $-0.04B | $0.02B | -179.31% |
| 2008-06-30 | $-0.03B | $0.02B | -165.71% |
| 2008-03-31 | $-0.03B | $0.02B | -190.16% |
| 2007-12-31 | $-0.27B | $0.01B | -2101.96% |
| 2007-09-30 | $-0.01B | $0.01B | -171.43% |
| 2007-06-30 | $-0.01B | $0.00B | -258.82% |
| 2007-03-31 | $0.00B | $0.00B | 0.00% |
| 2006-12-31 | $0.00B | 0 | 0.00% |
| 2006-09-30 | $-0.25B | 0 | 0.00% |
| 2006-06-30 | $-0.25B | 0 | 0.00% |
| 2006-03-31 | $-0.25B | 0 | 0.00% |
| 2005-12-31 | $0.00B | 0 | 0.00% |
| 2005-09-30 | $0.00B | 0 | 0.00% |
| 2005-06-30 | $0.00B | 0 | 0.00% |
| 2005-03-31 | $0.00B | 0 | 0.00% |
| 2004-12-31 | $0.00B | 0 | 0.00% |
| 2004-09-30 | $0.00B | 0 | 0.00% |
| 2004-06-30 | $-0.01B | $0.00B | -200.00% |
| 2004-03-31 | $-0.01B | $0.01B | -112.00% |
| 2003-12-31 | $-0.01B | $0.01B | -70.00% |
| 2003-09-30 | $-0.01B | $0.01B | -64.29% |
| 2003-06-30 | $-0.01B | $0.02B | -62.50% |
| 2003-03-31 | $-0.01B | $0.02B | -54.05% |
| 2002-12-31 | $-0.01B | $0.02B | -52.38% |
| 2002-09-30 | $-0.01B | $0.02B | -38.30% |
| 2002-06-30 | $-0.01B | $0.02B | -48.65% |
| 2002-03-31 | $-0.01B | $0.01B | -78.43% |
| 2001-12-31 | $-0.01B | $0.01B | -153.85% |
| 2001-09-30 | $-0.01B | 0 | 0.00% |
| 2001-06-30 | $-0.01B | 0 | 0.00% |
| 2001-03-31 | $-0.01B | 0 | 0.00% |
| 2000-12-31 | $-0.01B | 0 | 0.00% |
| 2000-09-30 | $-0.01B | 0 | 0.00% |
| 2000-06-30 | $-0.01B | 0 | 0.00% |
| 2000-03-31 | $-0.01B | 0 | 0.00% |
| 1999-12-31 | $0.00B | 0 | 0.00% |
| 1999-09-30 | $0.00B | 0 | 0.00% |
| 1999-06-30 | $0.00B | 0 | 0.00% |
| 1999-03-31 | $0.00B | 0 | 0.00% |
| 1998-12-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.164B | $0.607B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $133.518B | 45.26 |
| Edwards Lifesciences (EW) | United States | $49.242B | 30.43 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| Alcon (ALC) | Switzerland | $33.505B | 20.78 |
| DexCom (DXCM) | United States | $31.955B | 33.21 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Globus Medical (GMED) | United States | $10.173B | 15.40 |
| Glaukos (GKOS) | United States | $10.092B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| Veracyte (VCYT) | United States | $3.313B | 27.11 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.36 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |